Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
By application analysis In 2024, the type 2 diabetes mellitus segment led the GLP-1 receptor agonist market due to the high incidence of the disease and the major efficacy of these drugs in controlling blood sugar levels and encouraging weight loss, contributing majorly to the expansion of the type 2 diabetes mellitus segment
Preclinical Safety Data These side effects have not been confirmed in humans
R., & Hagen, T
This batch of Ipamorelin Growth Hormone Peptide has been third party lab tested and verified for quality
US$ 28.96
US$ 26.04
US$ 28.93
US$ 25.84
US$ 20.36
